Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Severstal recommended that dividends be paid for 2023

2/2/24 CHMF

Severstal reports for 2023

2/2/24 CHMF

Severstal's sales in 2023 decreased by 2%

2/2/24 CHMF

Samolet's profit increased by 23%

2/2/24 SMLT

Magnit launched the first order pickup point of the marketplace Magnit Market

2/1/24 MGNT

ICAO Headhunter placed an additional share issue to exchange HeadHunter shares

2/1/24 HEAD

UWC has changed its CEO again

2/1/24 UWGN

Board of Directors of Rosgosstrakh recommended that dividends be paid for 2022

1/31/24 RGSS

RusHydro summarized the results of its work in 2023

1/31/24 HYDR

Polymetal will talk about projects in Tajikistan

1/31/24 POLY